
Adamas Pharmaceuticals, Inc.
USD8.22
+0.00 (+0.00%)
CEO
Neil McFarlane
IPO Date
2014-04-10
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NASDAQ
Country
US
Open
$8.24
Prev. Close
$8.22
Day Low
$8.18
Day High
$8.25
52W Low
$4.02
52W High
$9.15
Volume
3.15M
| 11 Oct 2021 |
| William Blair |
| Outperform |
| Perform |
| downgrade |
| 7 Jun 2021 | HC Wainwright & Co. | Buy | Buy | maintain |
| 17 Dec 2019 | Cantor Fitzgerald | Neutral | Neutral | maintain |
| 30 Sept 2019 | Bank of America | Neutral | Underperform | downgrade |
| 9 Sept 2019 | Cantor Fitzgerald | Neutral | Neutral | maintain |
| 5 Mar 2019 | Needham | Buy | Hold | downgrade |
| 5 Mar 2019 | Cowen & Co. | Outperform | Perform | downgrade |